Two-Sigma-Investments-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
3,109
Total Value
44963769034
Accession Number
0000899140-25-000680
Form Type
13F-HR
Manager Name
Two-Sigma-Investments-Lp
Data Enrichment
86% identified
2,661 identified448 unidentified

Holdings

3,109 positions • $45.0B total value
Manager:
Search and click to pin securities to the top
Page 152 of 156
COGNITION THERAPEUTICS INC
Shares:82.5K
Value:$34.7K
% of Portfolio:0.0% ($34.7K/$45.0B)
ImmunoPrecise Antibodies Ltd.
Shares:90.6K
Value:$34.1K
% of Portfolio:0.0% ($34.1K/$45.0B)
biote Corp.
Shares:10.2K
Value:$34.0K
% of Portfolio:0.0% ($34.0K/$45.0B)
G6483G100
Shares:127.9K
Value:$32.9K
% of Portfolio:0.0% ($32.9K/$45.0B)
Gogoro Inc.
Shares:120.0K
Value:$32.4K
% of Portfolio:0.0% ($32.4K/$45.0B)
G6333L200
Shares:25.2K
Value:$31.1K
% of Portfolio:0.0% ($31.1K/$45.0B)
Maison Solutions Inc.
Shares:30.0K
Value:$30.9K
% of Portfolio:0.0% ($30.9K/$45.0B)
G6169A104
Shares:21.1K
Value:$30.8K
% of Portfolio:0.0% ($30.8K/$45.0B)
BuzzFeed, Inc.
Shares:13.9K
Value:$29.7K
% of Portfolio:0.0% ($29.7K/$45.0B)
Cibus, Inc.
Shares:15.6K
Value:$29.1K
% of Portfolio:0.0% ($29.1K/$45.0B)
G29201103
Shares:22.3K
Value:$28.1K
% of Portfolio:0.0% ($28.1K/$45.0B)
Adaptimmune Therapeutics PLC
Shares:135.9K
Value:$26.8K
% of Portfolio:0.0% ($26.8K/$45.0B)
71910P203
Shares:76.4K
Value:$26.6K
% of Portfolio:0.0% ($26.6K/$45.0B)
Skye Bioscience, Inc.
Shares:16.6K
Value:$26.4K
% of Portfolio:0.0% ($26.4K/$45.0B)
Cellectar Biosciences, Inc.
Shares:83.1K
Value:$26.2K
% of Portfolio:0.0% ($26.2K/$45.0B)
Outlook Therapeutics, Inc.
Shares:20.7K
Value:$25.3K
% of Portfolio:0.0% ($25.3K/$45.0B)
Lyra Therapeutics, Inc.
Shares:193.1K
Value:$24.4K
% of Portfolio:0.0% ($24.4K/$45.0B)
042255109
Shares:24.1K
Value:$24.1K
% of Portfolio:0.0% ($24.1K/$45.0B)
BIOMERICA INC
Shares:42.4K
Value:$24.0K
% of Portfolio:0.0% ($24.0K/$45.0B)
Seres Therapeutics, Inc.
Shares:32.3K
Value:$22.6K
% of Portfolio:0.0% ($22.6K/$45.0B)